186 related articles for article (PubMed ID: 8355199)
1. 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
Meisheri KD; Humphrey SJ; Khan SA; Cipkus-Dubray LA; Smith MP; Jones AW
J Pharmacol Exp Ther; 1993 Aug; 266(2):655-65. PubMed ID: 8355199
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
Ohrnberger CE; Khan SA; Meisheri KD
J Pharmacol Exp Ther; 1993 Oct; 267(1):25-30. PubMed ID: 8229751
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.
Wellman GC; Barrett-Jolley R; Köppel H; Everitt D; Quayle JM
Br J Pharmacol; 1999 Oct; 128(4):909-16. PubMed ID: 10556925
[TBL] [Abstract][Full Text] [Related]
4. Vascular pharmacology of ATP-sensitive K+ channels: interactions between glyburide and K+ channel openers.
Meisheri KD; Khan SA; Martin JL
J Vasc Res; 1993; 30(1):2-12. PubMed ID: 8435468
[TBL] [Abstract][Full Text] [Related]
5. Functional receptors in Xenopus oocytes for U-37883A, a novel ATP-sensitive K+ channel blocker: comparison with rat insulinoma cells.
Guillemare E; Honore E; De Weille J; Fosset M; Lazdunski M; Meisheri K
Mol Pharmacol; 1994 Jul; 46(1):139-45. PubMed ID: 8058048
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of the K-ATP channel blocker U-37883A and structurally related morpholinoguanidines.
Humphrey SJ; Smith MP; Cimini MG; Buchanan LV; Gibson JK; Khan SA; Meisheri KD
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):247-60. PubMed ID: 8803957
[TBL] [Abstract][Full Text] [Related]
7. Selective in vivo antagonism of pinacidil-induced hypotension by the guanidine U37883A in anesthetized rats.
Smith MP; Humphrey SJ; Jackson WF
Pharmacology; 1994 Dec; 49(6):363-75. PubMed ID: 7878074
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
Löffler-Walz C; Quast U
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):230-7. PubMed ID: 9750009
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
Teramoto N
Cardiovasc Drug Rev; 2006; 24(1):25-32. PubMed ID: 16939631
[TBL] [Abstract][Full Text] [Related]
10. Effects of U-37883A, a vascular selective KATP+ channel antagonist, in the pulmonary and hindlimb circulation.
DeWitt BJ; Cheng DY; McMahon TJ; Marrone JR; Champion HC; Kandowitz PJ
Am J Physiol; 1996 Dec; 271(6 Pt 1):L924-31. PubMed ID: 8997262
[TBL] [Abstract][Full Text] [Related]
11. Ba2+ differentially inhibits the Rb+ efflux promoting and the vasorelaxant effects of levcromakalim and minoxidil sulfate in rat isolated aorta.
Quast U; Baumlin Y; Loffler C
Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 353(1):86-93. PubMed ID: 8750921
[TBL] [Abstract][Full Text] [Related]
12. Effects of several potassium channel openers and glibenclamide on the uterus of the rat.
Piper I; Minshall E; Downing SJ; Hollingsworth M; Sadraei H
Br J Pharmacol; 1990 Dec; 101(4):901-7. PubMed ID: 2128195
[TBL] [Abstract][Full Text] [Related]
13. K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries.
Ploug KB; Boni LJ; Baun M; Hay-Schmidt A; Olesen J; Jansen-Olesen I
Br J Pharmacol; 2008 May; 154(1):72-81. PubMed ID: 18332850
[TBL] [Abstract][Full Text] [Related]
14. Guanidine derivative U-37883A, inhibits mitochondrial K+ uniport.
Szewczyk A; Wójcik G; Jabłonowska A; Nałecz
Pol J Pharmacol; 1995; 47(4):339-44. PubMed ID: 8616514
[TBL] [Abstract][Full Text] [Related]
15. Renal and vascular effects of chemically distinct ATP-sensitive K+ channel blockers in rats.
Ludens JH; Clark MA; Smith MP; Humphrey SJ
J Cardiovasc Pharmacol; 1995 Mar; 25(3):404-9. PubMed ID: 7769805
[TBL] [Abstract][Full Text] [Related]
16. Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
Tomoda T; Yunoki T; Naito S; Ito Y; Teramoto N
Eur J Pharmacol; 2005 Nov; 524(1-3):1-10. PubMed ID: 16242124
[TBL] [Abstract][Full Text] [Related]
17. Lack of effect of potassium channel openers on ATP-modulated potassium channels recorded from rat ventromedial hypothalamic neurones.
Sellers AJ; Boden PR; Ashford ML
Br J Pharmacol; 1992 Dec; 107(4):1068-74. PubMed ID: 1467829
[TBL] [Abstract][Full Text] [Related]
18. Epithelium-dependent inhibition of cholinergic transmission in rat isolated trachea by potassium channel openers.
Fabiani ME; Vlahos R; Story DF
Pharmacol Res; 1996; 33(4-5):261-72. PubMed ID: 8938019
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
Atwal KS
J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
